Physician

Devin Matthew Cunning, M.D.

According to 2025 Medicare claims, Devin Cunning, M.D. (NPI: 1629035944) practices otolaryngology in the Lake Havasu City-Kingman, AZ market, with the plurality of this provider's patient population coming from Mohave, AZ. This provider's primary affiliated billing organization is ARIZONA COAST EAR, NOSE & THROAT, LTD. (NPI: 1467583898; TIN: 861019440) and primary practice location at 86403-9998.

Cunning's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,750 traditional Medicare patients, billed 11,853 HCPCS/CPT codes, and received $479,867 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 806 prescription claims across 293 beneficiaries totaling $102,319 in drug costs, led by Nucala (Mepolizumab). DME data shows 2,746 claims. Open Payments data shows 44 records totaling $2,758. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $70,185 to $116,140.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,836	12,640	$486,956
2016	1,992	15,385	$499,715
2017	1,930	13,798	$432,450
2018	1,821	12,229	$404,223
2019	1,854	12,749	$429,819
2020	1,797	12,306	$380,512
2021	1,994	15,163	$537,483
2022	2,184	15,846	$504,124
2023	2,048	13,261	$544,490
2024	1,750	11,853	$479,867

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	387	1,257	$56,990
2016	332	1,019	$39,340
2017	298	1,056	$48,169
2018	294	1,030	$41,230
2019	305	1,027	$35,294
2020	334	1,047	$36,818
2021	295	898	$38,373
2022	258	724	$60,529
2023	253	754	$56,087
2024	293	806	$102,319

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	530	1,068	$69,236
2016	563	1,128	$58,795
2017	558	1,153	$33,475
2018	784	1,505	$50,697
2019	985	2,252	$77,366
2020	1,315	2,997	$129,486
2021	1,338	3,220	$140,333
2022	1,328	2,808	$140,587
2023	1,425	3,306	$172,379
2024	1,177	2,746	$113,867

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	254	254	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	388	495	$84
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	255	256	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	836	1,134	$58
69210	Removal of impacted ear wax	344	414	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nucala	Mepolizumab	13	476	$68,756
Levothyroxine Sodium	Levothyroxine Sodium	323	23,463	$2,986
Synthroid	Levothyroxine Sodium	23	1,412	$1,107
Fluticasone Propionate	Fluticasone Propionate	34	1,920	$647
Ofloxacin	Ofloxacin	13	178	$565

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	78	182	$16,289
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	67	167	$14,645
A7030	Full face mask used with positive airway pressure device, each	N	74	173	$13,695
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	104	258	$13,629
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	137	328	$12,364

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$2,758	AERIN MEDICAL INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Devin Matthew Cunning, M.D.?

Tedicare shows public-source Medicare data for Devin Matthew Cunning, M.D. (NPI 1629035944), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Devin Matthew Cunning, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Devin Matthew Cunning, M.D.?

Devin Matthew Cunning, M.D. is linked to ARIZONA COAST EAR, NOSE & THROAT, LTD. (billing NPI 1467583898) in the available physician profile data.

Does Devin Matthew Cunning, M.D. have Open Payments data?

Devin Matthew Cunning, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.